🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
145.83
+0.24 (0.16%)
At close: Nov 20, 2026, 4:00 PM EST
147.88
+2.05 (1.41%)
After-hours: Nov 20, 2026, 7:50 PM EST

Guardant Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-485.07-416.28-436.37-479.45-654.59-405.67
Depreciation & Amortization
39.2339.7442.3942.8835.9622.27
Other Amortization
----2.572.56
Loss (Gain) From Sale of Investments
0.5212.7137.63-64.2117.6512.85
Stock-Based Compensation
210.96166.22140.4190.7694.69151.45
Other Operating Activities
45.1627.2936.9531.2132.747.99
Change in Accounts Receivable
-70.6-28.18-21.398.380.38-44.35
Change in Inventory
-3-14.79-9.14-10.35-20.93-7.96
Change in Accounts Payable
131.5152.75-2.825.1960.3334.8
Change in Unearned Revenue
-10.919.4618.661.739.872.78
Change in Other Net Operating Assets
-31.28-43.67-46.1848.8911.91-25.73
Operating Cash Flow
-173.48-184.76-239.86-324.98-309.46-209.02
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-58.67-48.31-35.09-20.49-77.46-75.04
Cash Acquisitions
-58.99-58.99----
Investment in Securities
-0-519.91-226.22860.74227.2811.88
Investing Cash Flow
-117.66-627.2-261.31840.25149.82-63.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-402.5----
Net Debt Issued (Repaid)
402.5402.5----
Issuance of Common Stock
415.38377.8114.84503.6811.9417.87
Repurchase of Common Stock
-44.15-75.55-15.68-11.2-7.88-83.76
Other Financing Activities
-25.25-33.63-0.15-15.1-193.16-0.93
Financing Cash Flow
748.48671.13-1477.38-189.09-66.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.850.49-1.77-0.91-1.6-1.69
Net Cash Flow
456.49-140.34-503.93991.74-350.34-340.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-232.15-233.07-274.94-345.46-386.92-284.05
Free Cash Flow Growth
------
Free Cash Flow Margin
-18.15%-23.73%-37.20%-61.26%-86.07%-76.02%
Free Cash Flow Per Share
-1.76-1.86-2.24-3.08-3.79-2.80
Levered Free Cash Flow
-60.54-88.11-148.78-180.7-295.57-123.48
Unlevered Free Cash Flow
-57.27-85.67-147.16-179.09-296.52-124.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.773.77----
Cash Income Tax Paid
0.870.871.011.971.330.39
Change in Working Capital
15.73-14.43-60.8653.8461.56-40.47
SEC Filings: 10-K · 10-Q